Statements
2021 DSV Opinion on Europe's plan for beating cancer
2021 DSV Statement Impact Assessment Revision Pharmaceutical Legislation
2021 DSV Statement Impact Assessment Mercury Regulation
DSV Feedback on BECA Survey COVID-19/Cancer
2021 DSV Feedback on the Inception Impact Assessment on HERA
DSV Opinion on the Roadmap to establish an European Health Data Space
2021 DSV Opinion on the Pharmaceutical Strategy
2020 DSV Statement Revision of regulations on paediatric and OMP
2020 DSV Opinion on the European Health Union
2020 DSV Food for thought Medicines for future generations
2020 DSV Opinion on the roadmap for the pharmaceutical strategy
2020 GKV-SV Ensuring security of supply of medical devices in Europe even during COVID-19 pandemic.
2020 Comments by the German Social Insurance (Roadmap Europe's Beating Cancer Plan)
2018 GKV-SV Reflections on the Draft Report and proposals for amendments
2018 GKV-SV HTA EN
2018 GKV-SV HTA FR
2018 DSV Food for Thought paper capitalize on digitalisation - healthy, united, European
2017 GKV-SV Reform EC 883/2004 and EC 987/2009_en
2017 GKV-SV Paediatric Regulation 
GKV-SV HTA
2016 GKV-SV safety of apps
2016 GKV-SV_Amendments-to-Regulation-EC-726_2004_en
2015 ESIP-AIM Access to innovative medicines 
2018 GKV-SV HTA FR
2015 GKV-SV medical devices
2014 GKV-SV shaping health in Europe
2014 DSV Mobile Health Dienste Anhang 1
2014 DSV Mobile Health Dienste Anhang 2
2014 GKV SV mhealth
2014 GKV SV patient safety
- 2018 DSV Food for Thought paper capitalize on digitalisation - healthy, united, European
- 2017 GKV-SV Reform EC 883/2004 and EC 987/2009_en
- 2017 GKV-SV Paediatric Regulation
- GKV-SV HTA
- 2016 GKV-SV safety of apps
- 2016 GKV-SV_Amendments-to-Regulation-EC-726_2004_en
- 2015 ESIP-AIM Access to innovative medicines
- 2015 GKV-SV medical devices
- 2014 GKV-SV shaping health in Europe
- 2014 DSV Mobile Health Dienste Anhang 1
- 2014 DSV Mobile Health Dienste Anhang 2
- 2014 GKV SV mhealth
- 2014 GKV SV patient safety